Tyra Biosciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights

Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor ...

Zymeworks Inc. Q4 2025 Earnings Call Summary

Strategic positioning is being strengthened by transferring late-stage development costs to partners like Jazz and BeiGene, ...